- Recent Funding
- Investors
- Aisling Capital
Aisling Capital portfolio
Aisling Capital has 3 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It is a venture capital firm based in New York, US, founded in 2000. It led 1 of the 2 rounds it joined. Its most recent investment on record is Claris Bio's $118M Series B+ round in July 2026, alongside Novo Holdings, Adage Capital Management, Janus Henderson Investors and 5 others. By category, its portfolio leans toward Health and bio (3) and Manufacturing and industrial (2). It has co-invested with Sofinnova Partners, Novo Holdings and Janus Henderson Investors.
About Aisling Capital
Fund returns
| Fund | Vintage | Size | Net IRR | TVPI | DPI | As of |
|---|---|---|---|---|---|---|
| Aisling Capital IV, L.P. | 2015 | — | 11.6% | 1.74x | 0.68x | Sep 30, 2025 |
| Aisling Capital III | 2008 | — | 26.4% | 2.38x | 2.38x | Jun 30, 2025 |
| Aisling Capital III, L.P. | 2008 | — | 26.5% | 2.38x | 2.38x | Sep 30, 2025 |
| Aisling Capital II | 2006 | — | 0.6% | 1.04x | 1.04x | Jun 30, 2025 |
| Aisling Capital II, L.P. | 2005 | — | 0.9% | 1.06x | 0.99x | Sep 30, 2025 |
What Aisling Capital invests in
- Health and bio · 3 · 100%
- Manufacturing and industrial · 2 · 67%
How Aisling Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 2 100% | $208M |
Aisling Capital portfolio companies
CClaris Bio$118MSeries B+ · Jul 2026
FForge Biologics$90MSeries B+ · Sep 2022
TTreeline Biosciencesbacker
| Company | Round with Aisling Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $118M | $175M | Jul 28, 2026 Series B+ |
Health and bio |
Series B+ · $90M · lead | $250M | Sep 12, 2022 Series B+ |
Health and bio |
backer | $461M | Sep 3, 2025 Series A |
Most frequent co-investors
SSofinnova Partners1 shared round · last Jul 28, 2026
NNovo Holdings1 shared round · last Jul 28, 2026
JJanus Henderson Investors1 shared round · last Jul 28, 2026
AAdage Capital Management1 shared round · last Jul 28, 2026
MMass General Brigham Ventures1 shared round · last Jul 28, 2026
SSamsara Biocapital1 shared round · last Jul 28, 2026
CCatalio1 shared round · last Jul 28, 2026
AADAR1 Capital Management1 shared round · last Jul 28, 2026
DDrive Capital1 shared round · last Sep 12, 2022
Similar investors
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
GGenoa Ventures5 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Net returns as reported by the public-pension and foundation LPs invested in each fund.
Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 2 rounds on Recent Funding that name Aisling Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Aisling Capital, which is a subset of its real portfolio. API: /api/v1/investors/aisling-capital (get a free API key). More: the most active VC firms and new venture capital funds.